{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:21:03Z","timestamp":1784614863140,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113460","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T23:10:46Z","timestamp":1731021046000},"page":"113460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P2","title":["Diltiazem mitigates acute liver injury by targeting NF\u03baB-TXNIP\/NLRP3 axis in Rats: New insights beyond calcium channel blockade"],"prefix":"10.1016","volume":"143","author":[{"given":"Fatma","family":"Elnaghy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.G.","family":"Shehatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Abd El-Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113460_b0005","series-title":"Acute Hepatitis, StatPearls, StatPearls Publishing. Copyright \u00a9 2023","author":"Schaefer","year":"2023"},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41419-024-06537-5","article-title":"Hepatic Sirt6 activation abrogates acute liver failure","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2024.113460_b0015","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41380-022-01615-6","article-title":"Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders","volume":"27","author":"Colbourne","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.intimp.2024.113460_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102572","article-title":"Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels","author":"Vaiciuleviciute","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0976-500X.119707","article-title":"Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride","volume":"4","author":"Vasigar","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"issue":"2","key":"10.1016\/j.intimp.2024.113460_b0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.109.200311","article-title":"L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages","volume":"105","author":"Das","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2024.113460_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113000","article-title":"Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NF\u03baB\/NLRP3\/IL-1\u03b2 signaling in rats: Unraveling new roles beyond calcium channel blocking","volume":"141","author":"Kira","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18203\/2319-2003.ijbcp20185157","article-title":"Comparative study of anti-inflammatory property of calcium channel blocker and aspirin in albino rats","volume":"8","author":"Jabeen","year":"2018","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10753-020-01215-y","article-title":"Nicardipine Inhibits Priming of the NLRP3 Inflammasome via Suppressing LPS-Induced TLR4 Expression","volume":"43","author":"Chang","year":"2020","journal-title":"Inflammation"},{"issue":"13","key":"10.1016\/j.intimp.2024.113460_b0050","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1111\/jcmm.16357","article-title":"Verapamil inhibits early acute liver failure through suppressing the NLRP3 inflammasome pathway","volume":"25","author":"Han","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0055","first-page":"Pi30-6","article-title":"Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass?","volume":"9","author":"Fansa","year":"2003","journal-title":"Med Sci Monit"},{"issue":"971","key":"10.1016\/j.intimp.2024.113460_b0060","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/pgmj.2006.045302","article-title":"Anti-inflammatory action of diltiazem in patients with unstable angina","volume":"82","author":"Dubey","year":"2006","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.intimp.2024.113460_b0065","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2024.113460_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122966","article-title":"Modulating the HSP90 control over NF\u03baB\/NLRP3\/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)","volume":"354","author":"Elmorsy","year":"2024","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043067","article-title":"The Role of the NLRP3 Inflammasome and Programmed Cell Death in Acute Liver Injury","volume":"24","author":"Yu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.intimp.2024.113460_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052754","article-title":"Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook","volume":"22","author":"Qayyum","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.intimp.2024.113460_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13050545","article-title":"Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host-Pathogen Dynamics","author":"Dagah","year":"2024","journal-title":"Antioxidants"},{"issue":"13","key":"10.1016\/j.intimp.2024.113460_b0090","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1089\/ars.2014.6126","article-title":"Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit","volume":"22","author":"Mohamed","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.intimp.2024.113460_b0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2024.113460_b0100","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4239\/wjd.v12.i12.1979","article-title":"Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response","volume":"12","author":"Mohamed","year":"2021","journal-title":"World J Diabetes"},{"issue":"23","key":"10.1016\/j.intimp.2024.113460_b0105","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17489","article-title":"Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1476-5381.2011.01336.x","article-title":"Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity","volume":"164","author":"Al-Gayyar","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbrc.2019.02.141","article-title":"TXNIP-mediated nuclear factor-\u03baB signaling pathway and intracellular shifting of TXNIP in uric acid-induced NLRP3 inflammasome","volume":"511","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2613.2008.00576.x","article-title":"Single dose intravenous thioacetamide administration as a model of acute liver damage in rats","volume":"89","author":"Chen","year":"2008","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.intimp.2024.113460_b0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.lfs.2019.05.019","article-title":"Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4\/NF-KB signaling pathway in mice","volume":"228","author":"El-Kashef","year":"2019","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.intimp.2024.113460_b0130","doi-asserted-by":"crossref","first-page":"e22496","DOI":"10.1096\/fj.202200749R","article-title":"Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-\u03baB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis","volume":"36","author":"Cavalu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.113460_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112731","article-title":"Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-\u03baB signaling: A new challenge for unmet therapeutic needs","volume":"148","author":"Saber","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.intimp.2024.113460_b0140","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00210-018-1540-2","article-title":"Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation","volume":"391","author":"Dwivedi","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"D1","key":"10.1016\/j.intimp.2024.113460_b0145","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem Substance and Compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"10.1016\/j.intimp.2024.113460_b0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.113460_b0155","first-page":"455","article-title":"Antihypertensive effect of diltiazem in young or adult rats of genetically hypertensive strains, Clinical and Experimental Hypertension","volume":"5","author":"Takata","year":"1983","journal-title":"Part a: Theory and Practice"},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-5173(91)90345-O","article-title":"Pharmacokinetics of diltiazem and deacetyldiltiazem in rats","volume":"76","author":"Lee","year":"1991","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.intimp.2024.113460_b0165","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cbf.3839","article-title":"Coleus vettiveroides ethanolic root extract protects against thioacetamide-induced acute liver injury in rats","volume":"41","author":"Mohamed Azar","year":"2023","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"10.1016\/j.intimp.2024.113460_b0170","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajg.2023.07.005","article-title":"Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation","volume":"25","author":"Pithani","year":"2024","journal-title":"Arab Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113460_b0180","doi-asserted-by":"crossref","first-page":"e09198","DOI":"10.1016\/j.heliyon.2022.e09198","article-title":"Cytoprotective potentialities of carvacrol and its nanoemulsion against cisplatin-induced nephrotoxicity in rats: development of nano-encasulation form","volume":"8","author":"Ragab","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2024.113460_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.893919","article-title":"N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding","volume":"14","author":"Cheng","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10787-022-01130-8","article-title":"Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases","volume":"31","author":"Zhou","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"39","key":"10.1016\/j.intimp.2024.113460_b0195","doi-asserted-by":"crossref","first-page":"27159","DOI":"10.1074\/jbc.M114.567537","article-title":"Nod-like Receptor Protein 3 (NLRP3) Inflammasome Activation and Podocyte Injury via Thioredoxin-Interacting Protein (TXNIP) during Hyperhomocysteinemia*","volume":"289","author":"Abais","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.113460_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113247","article-title":"Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis","volume":"153","author":"Shaaban","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113460_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114553","article-title":"Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model","volume":"161","author":"Abdelhady","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113460_b0210","doi-asserted-by":"crossref","first-page":"1178662","DOI":"10.3389\/fimmu.2023.1178662","article-title":"Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors","volume":"14","author":"Dai","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113460_b0215","doi-asserted-by":"crossref","first-page":"e0292655","DOI":"10.1371\/journal.pone.0292655","article-title":"TXNIP-mediated crosstalk between oxidative stress and glucose metabolism","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2024.113460_b0220","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/ars.2014.5868","article-title":"Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.intimp.2024.113460_b0225","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.113460_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113409","article-title":"Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK\/NF-\u03baB\/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis","volume":"153","author":"Nasr","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"null","key":"10.1016\/j.intimp.2024.113460_b0235","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.2147\/JIR.S315938","article-title":"The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis","volume":"14","author":"Saber","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.113460_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112723","article-title":"Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-\u03baB and NLRP3 crosstalk: A novel approach for filling an unmet medical need","volume":"148","author":"Zohny","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113460_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00514","article-title":"Thioredoxin\/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases","volume":"4","author":"Yoshihara","year":"2014","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113460_b0250","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","article-title":"TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113460_b0255","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113460_b0260","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00542114","article-title":"Hypotensive effects of diltiazem to normals and essential hypertensives","volume":"25","author":"Aoki","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:33:32Z","timestamp":1736303612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924019829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S1567576924019829"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113460","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diltiazem mitigates acute liver injury by targeting NF\u03baB-TXNIP\/NLRP3 axis in Rats: New insights beyond calcium channel blockade","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113460"}}